Engineered nanocarriers for simultaneous anticancer immune response and “switching” of tumor-associated macrophages for intranasal glioblastoma treatment

Project Information

BraINstorm

Grant agreement ID: 887609

DOI 10.3030/887609

Project closed

EC signature date 27 February 2020

Start date 1 September 2020

End date 31 August 2022

Funded under

• EXCELLENT SCIENCE - Marie Skłodowska-Curie Actions

Total cost € 166 320,00

EU contribution € 166 320,00

Coordinated by

UNIVERSITE CATHOLIQUE DE LOUVAIN
Belgium

CORDIS provides links to public deliverables and publications of HORIZON projects.

Links to deliverables and publications from FP7 projects, as well as links to some specific result types such as dataset and software, are dynamically retrieved from OpenAIRE .

Publications

Peer reviewed articles (1)

Combination of DNA Vaccine and Immune Checkpoint Blockades Improves the Immune Response in an Orthotopic Unresectable Glioblastoma Model

Author(s): M. Bausart, K. Vanvarenberg, B. Ucakar, A. Lopes, G. Vandermeulen, A. Malfanti, V. Préat,
Published in: Pharmaceutics, 14,1025, 2022, ISSN 1999-4923
Publisher: Multidisciplinary Digital Publishing Institute (MDPI)
DOI: 10.3390/pharmaceutics14051025